Skip to main content

Advertisement

Log in

The expression of cyclin G in nasopharyngeal carcinoma and its significance

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

To investigate the expression of cyclin G1, cyclin G2 in nasopharyngeal carcinoma (NPC) cell lines and its significance. The protein expression of cyclin G1, cyclin G2 in NPC cell lines of different differentiation degree (HNE2, CNE1) was detected by indirect immunofluorescence. The mRNA expression of cyclin G1, cyclin G2 in HNE2 and CNE1 was measured with RT–PCR. The cyclin G1 expression in HNE2 and CNE1 was weak, and cyclin G2 expression in the cytoplasm near cell membrane was strong, continuous, and homogeneous. The expression level of cyclin G1-mRNA in HNE2 was 2.097 ± 0.262, which was significantly higher than CNE1 (0.997 ± 0.286, P < 0.05); the expression level of cyclin G2-mRNA in HNE2 was 0.708 ± 0.107, which was significantly lower than CNE1 (1.216 ± 0.037, P < 0.05). Abnormal expression of cyclin G was closely related to tumor differentiation, the origin, and progression of NPC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Chou J, Lin YC, Kim J et al (2008) Nasopharyngeal carcinoma–review of the molecular mechanisms of tumorigenesis. Head Neck 30:946–963

    Article  PubMed  Google Scholar 

  2. Cui X, Niu Z, Liu A (2008) Hou lin ai zu zhi Cyclin G1, G2 gene expression and clinical significance [Chinese]. Zhong Hua Zhong Liu Fang Zhi Za Zhi 15:597–599

    CAS  Google Scholar 

  3. Fornari F, Gramantieri L, Giovannini C et al (2009) MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 69:5761–5767

    Article  PubMed  CAS  Google Scholar 

  4. Galanis E, Carlson SK, Foster NR et al (2008) Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer. Mol Ther 16:979–984

    Article  PubMed  CAS  Google Scholar 

  5. Horne MC, Goolsby GL, Donaldson KL et al (1996) Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression. J Biol Chem 271:6050–6061

    Article  PubMed  CAS  Google Scholar 

  6. Jensen MR, Audolfsson T, Keck CL et al (1999) Gene structure and chromosomal localization of mouse cyclin G2 (Ccng2). Gene 230:171–180

    Article  PubMed  CAS  Google Scholar 

  7. Kimura SH, Kataoka TR, Endo Y, Nojima H (1997) Genomic structure and chromosomal localization of mouse cyclin G1 gene. Genomics 46:483–486

    Article  PubMed  CAS  Google Scholar 

  8. Martinez-Gac L, Marques M, Garcia Z et al (2004) Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol Cell Biol 24:2181–2189

    Article  PubMed  CAS  Google Scholar 

  9. Pedeux R, Lefort K, Cuenin C et al (2002) Specific induction of gadd45 in human melanocytes and melanoma cells after UVB irradiation. Int J Cancer 98:811–816

    Article  PubMed  CAS  Google Scholar 

  10. Ye M, Liu JK, Lu ZX et al (2005) Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, inhibits tumor cell growth by inducing apoptosis in vitro. FEBS Lett 579:3437–3443

    Article  PubMed  CAS  Google Scholar 

  11. Ye M, Luo X, Li L et al (2007) Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway. Cancer Lett 258:199–207

    Article  PubMed  CAS  Google Scholar 

  12. Yue L, Daikoku T, Hou X et al (2005) Cyclin G1 and cyclin G2 are expressed in the periimplantation mouse uterus in a cell-specific and progesterone-dependent manner: evidence for aberrant regulation with Hoxa-10 deficiency. Endocrinology 146:2424–2433

    Article  PubMed  CAS  Google Scholar 

  13. Zhao L, Samuels T, Winckler S et al (2003) Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2–p53 and pRb tumor suppressor pathways. Mol Cancer Res 1:195–206

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cai Zhi-yi.

Additional information

Xing-Xing Ye and Chi-Bo Liu contributed to the paper equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ye, XX., Liu, CB., Chen, Jy. et al. The expression of cyclin G in nasopharyngeal carcinoma and its significance. Clin Exp Med 12, 21–24 (2012). https://doi.org/10.1007/s10238-011-0142-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-011-0142-9

Keywords

Navigation